University of Birmingham researchers develop rapid COVID-19 RNA test
Test can give accurate results in under five minutes, according to researchers
6th January 2021
Test can give accurate results in under five minutes, according to researchers
6th January 2021
Key focus of the deal is focal-onset seizure treatment cenobamate
5th January 2021
Company is aiming for approval in the adjuvant setting
5th January 2021
The total value of all payments for the Atacand brand is $400m
5th January 2021
New Innovative Licensing and Access Pathway launched
5th January 2021
Drug is being reviewed for ALK-positive lung cancer
4th January 2021
KRAS mutations are found in several hard-to-treat cancers
4th January 2021
Submission based on results from phase I CHRYSALIS study
4th January 2021
Shot was approved by MHRA on 30 December
4th January 2021
Ebanga approved to treat Ebola in adult and paediatric patients
24th December 2020
Submission supported by results from phase II CodeBreaK 100 study
24th December 2020
REACH-CDM study was based on results of positive phase II data
24th December 2020
Drug is being studied in hospitalised COVID-19 patients
23rd December 2020
Oral solution approved to treat seizures associated with Dravet syndrome
23rd December 2020
Payment for drug linked to value to NHS rather than volume used
23rd December 2020